Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

NCT01928225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Cervical High Grade Squamous Intraepithelial Lesion

Interventions

BIOLOGICAL: Human Papillomavirus vaccine

Sponsor

University of Witwatersrand, South Africa

Collaborators

[object Object]